Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shockFRONTIERS IN IMMUNOLOGYIF5.92023-09-155OAAI
Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52022-02-158OAAI
Pseudomonas aeruginosa Ventilator-Associated Pneumonia Rabbit Model for Preclinical Drug DevelopmentANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-06-1711OA
Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint InfectionANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-06-1710OA
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureusFRONTIERS IN IMMUNOLOGYIF5.92021-03-1023OAAI
Staphylococcus aureus Interferes with Streptococci Spatial Distribution and with Protein Expression of Species within a Polymicrobial Oral BiofilmANTIBIOTICS-BASELIF4.62021-01-269OAAI
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug DevelopmentFDA公共研讨会摘要: 推进抗菌药物开发的动物模型ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52020-12-1616OAAI
Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing PneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52020-02-2114OAAI
Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing PneumoniaJOURNAL OF INFECTIOUS DISEASESIF4.52019-08-2631OAAI
Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit ModelsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-08-0124OAAI
Necrotizing Soft Tissue Infection Staphylococcus aureus but not S. pyogenes Isolates Display High Rates of Internalization and Cytotoxicity Toward Human MyoblastsJOURNAL OF INFECTIOUS DISEASESIF4.52019-04-199OAAI
MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52018-05-0130OAAI
Neonatal priming shapes preferential capacity for immune tolerance to skin commensal vs. pathogenic bacteriaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-010OAAI
Demographic fluctuation of community-acquired antibiotic-resistant Staphylococcus aureus lineages: potential role of flimsy antibiotic exposureISME JOURNALIF102018-03-299OAAI
The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus抗生素在金黄色葡萄球菌毒力调节中的作用CLINICAL MICROBIOLOGY REVIEWSIF19.32017-10-01111OAAI
Effects of Tedizolid Phosphate on Survival Outcomes and Suppression of Production of Staphylococcal Toxins in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing PneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52017-04-017OAAI
Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing PneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52017-04-0140OAAI
Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-HemolysinANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52016-10-0166OAAI
Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure InfectionsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52016-10-0130OAAI
IVIG-mediated protection against necrotizing pneumonia caused by MRSASCIENCE TRANSLATIONAL MEDICINEIF14.62016-09-2165OAAI